Stay updated on PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.

Latest updates to the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision note v3.5.0 has been added and the v3.4.3 revision note has been removed.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page header now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was added; the notices for government funding lapse and Revision: v3.4.1 were removed. These updates are routine and do not alter the study content.SummaryDifference0.2%

- Check61 days agoChange DetectedA government funding and operations notice is now displayed on the page, and the revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedAdded a 'Show glossary' option and a new 'Last Update Submitted that Met QC Criteria' field, along with a revision label 'Revision: v3.4.0'. Minor capitalization changes to the 'No FEAR Act data' label were also made; these are UI metadata updates that do not affect study content.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Revision: v3.3.4; Removed Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.